Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expression

This publication has 20 references indexed in Scilit:

• Expression of c-erbb-2 protein and epidermal growth factor receptor in endometrial carcinomas correlation with clinicopathologic and sex steroid receptor status
  Cancer, 1993
• HER-2/neu expression: A major prognostic factor in endometrial cancer
  Gynecologic Oncology, 1992
• Immunohistochemical study of c‐erbB‐2 oncoprotein overexpression in human major salivary gland carcinoma: An indicator of aggressiveness
  The Laryngoscope, 1992
• Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus
  Cancer, 1992
• Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease
  American Journal of Obstetrics and Gynecology, 1991
• Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of Patients
  Japanese Journal of Cancer Research, 1990
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• The significance of residual disease after radiotherapy in endometrial carcinoma: Clinicopathologic correlation
  American Journal of Obstetrics and Gynecology, 1980
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958